News Quantified

SWTX – springworks therapeutics, inc. - common stock (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference [Yahoo! Finance]

SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $74.00 price target on the stock.

Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation [Yahoo! Finance]

-9.5%

BEAT

5.6%

BEAT

-6.9%

IN-LINE

Form 10-Q SpringWorks Therapeutics For: Mar 31

Form 8-K SpringWorks Therapeutics For: May 02

Form ARS SpringWorks Therapeutics For: Dec 31

Form DEFA14A SpringWorks Therapeutics

Form DEF 14A SpringWorks Therapeutics For: May 16

Top News Gainers

3/19 SpringWorks Therapeutics (NASDAQ: SWTX) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. 15.9%

12/9 Form 8-K SpringWorks Therapeutics For: Dec 09 7.2%

2/3 SpringWorks Therapeutics (NASDAQ: SWTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock. 7.1%

4/14 SpringWorks Therapeutics (NASDAQ: SWTX) had its price target lowered by analysts at HC Wainwright from $60.00 to $58.00. They now have a "buy" rating on the stock. 6.9%

2/14 Form SC 13G/A SpringWorks Therapeutics Filed by: PERCEPTIVE ADVISORS LLC 5.8%

9/19 Form 4 SpringWorks Therapeutics For: Sep 17 Filed by: Pfizer Ventures (US) LLC 5.3%

12/9 Researchers Present Preclinical Data Showing Synergistic Activity of SpringWorks Therapeutics’ Gamma Secretase Inhibitor (Nirogacestat) with GlaxoSmithKline’s BCMA Antibody-Drug Conjugate (Belantamab Mafodotin) at the American Society of Hematology (ASH) 4.6%

3/23 Form S-8 SpringWorks Therapeutics 4.0%

9/13 Form 424B4 SpringWorks Therapeutics 3.7%

9/26 Form SC 13G SpringWorks Therapeutics Filed by: PERCEPTIVE ADVISORS LLC 2.8%

Top News Decliners

3/13 Form 4 SpringWorks Therapeutics For: Mar 12 Filed by: SQUINTO STEPHEN P -27.1%

9/25 Form SC 13D SpringWorks Therapeutics Filed by: ORBIMED ADVISORS LLC -21.5%

9/12 Form 3 SpringWorks Therapeutics For: Sep 12 Filed by: Lewis-Hall Freda C -7.6%

3/4 Form 4 SpringWorks Therapeutics For: Mar 02 Filed by: Francis Perier I Jr -6.2%

1/6 SpringWorks Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference -5.8%

10/24 SpringWorks Therapeutics Announces Initiation of Phase 2b ReNeu Clinical Trial of Mirdametinib in Children and Adults with Neurofibromatosis Type 1 (NF1)-Associated Plexiform Neurofibromas (NF1-PN) -5.7%

10/29 Form S-8 SpringWorks Therapeutics -4.7%

2/5 Form 4 SpringWorks Therapeutics For: Feb 03 Filed by: Weinstein Herschel S -4.3%

12/4 SpringWorks Therapeutics (NASDAQ: SWTX) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. -4.0%

1/12 Here's Why SpringWorks Therapeutics Climbed 69% in December [The Motley Fool] -3.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day